Researcher
Isabel Spriet
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → Today - Department of Pharmaceutical and Pharmacological Sciences (Department)
Member
From17 Nov 2003 → 30 Sep 2005
Projects
1 - 10 of 21
- Leverage of a non-invasive clinical decision support tool for antibiotic allergy label delabeling and refinement beyond hospital use.From1 Oct 2023 → TodayFunding: IOF - technology validation in lab
- Non-invasive antibiotic allergy delabeling and refinement to optimize antimicrobial stewardshipFrom1 Oct 2023 → TodayFunding: FWO junior postdoctoral fellowship
- Assesment of the impact of a non-invasive clinical decision support tool for antibiotic allergy label delabeling and refinementFrom1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Optimizing Antibacterial Dosing in Special Patient PopulationsFrom24 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: STRADA-CEF trial.From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Antibacterial dose optimisation based on augmented renal clearance in adult critically ill patients and selected pediatric patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Mold-active Azoles: Development, Validation and Implementation of strategies for Safe and Effective Dosing (M-ADVISED)From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Exploration of the pharmacokinetics of clindamycin and its metabolites in special patients: from bioanalysis to clinical relevanceFrom1 Oct 2021 → 30 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Clinical validation of antifungal dosing strategies in critically ill patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Set up of pharmacy-based clinical pharmacy services, the cornerstone for patient safety in BelgiumFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 195
- Ten reasons for the presence of pharmacy professionals in the intensive care unit(2024)
Authors: Isabel Spriet
Pages: 147 - 149 - Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections(2023)
Authors: Saartje Uyttebroek, Willem-Jan Metsemakers, Yves Debaveye, Laura Van Gerven, Lieven Dupont, Melissa Depypere, Jeroen Wagemans, Rob Lavigne, Isabel Spriet, Jolien Onsea
- Assessment of in vitro antimicrobial activity of clindamycin metabolites against Staphylococcus species(2023)
Authors: Greet Van De Sijpe, Laura Armengol Álvarez, Agustos Cetin Ozbey, Karel Allegaert, Jef Rozenski, Pieter Annaert, Stefanie Desmet, Isabel Spriet
Pages: 1345 - 1347 - Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review(2022)
Authors: Saartje Uyttebroek, Baixing Chen, Jolien Onsea, Yves Debaveye, Isabel Spriet, Melissa Depypere, Jeroen Wagemans, Rob Lavigne, Paul De Munter, Willy Peetermans, et al.
Pages: E208 - E220 - Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function(2022)
Authors: Matthias Gijsen, Omar Elkayal, Pieter Annaert, Ruth Van Daele, Yves Debaveye, Joost Wauters, Erwin Dreesen, Isabel Spriet
Pages: 53 - 62 - Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU study(2022)
Authors: Ruth Van Daele, Joost Wauters, Erwin Dreesen, Lore Vanderbeke, Isabel Spriet
Pages: 656 - 660 - Improving appropriate use of anticoagulants in hospitalised patients: a pharmacist-led Check of Medication Appropriateness intervention.(2022)
Authors: Charlotte Quintens, Peter Verhamme, Thomas Vanassche, Christophe Vandenbriele, Bart Van den Bosch, Lorenz Van der Linden, Isabel Spriet
Pages: 2959 - 2968 - Drug-related hospital admissions in older adults: comparison of the Naranjo algorithm and an adjusted version of the Kramer algorithm(2022)
Authors: Beatrijs Mertens, Laura Hellemans, Isabel Spriet, Jos Tournoy, Lorenz Van der Linden
Pages: 567 - 577 - The TARGET trial as a plea for model-informed precision dosing of piperacillin/tazobactam in patients with sepsis(2022)
Authors: Matthias Gijsen, Erwin Dreesen, Joost Wauters, Yves Debaveye, Isabel Spriet
Pages: 768 - 769 - Inducers and Cardiovascular Risk-Potential Role for Lowered Drug Exposure(2022)
Authors: Lorenz Van der Linden, Isabel Spriet
Pages: 419 - 419